To address the root cause of CF and provide treatment for all patients, scientific efforts are currently focusing on the development of CFTR gene editing and gene transfer, which rely heavily on novel molecular approaches (e.g., readthrough, mRNA transfer/repair, short nucleotide therapies). This evidence concerns the gene CFTR and cystic fibrosis.